Implementation of fixed-dose combination therapy for secondary prevention of atherosclerotic cardiovascular disease among Syrian refugees in Lebanon: a qualitative evaluation.
Adrianna MurphyRuth WillisÉimhín AnsbroSahar MasriNour KabbaraTonia DabbousySola BahousLucas MolfinoPablo PerelPhilippa BoullePublished in: BMC health services research (2022)
For patients and clinic staff, FDC was an acceptable treatment approach for secondary prevention of ASCVD disease in two MSF clinics in Lebanon. Sustainability is more complex and calls for better alignment of care with public systems.
Keyphrases
- combination therapy
- primary care
- healthcare
- cardiovascular disease
- end stage renal disease
- newly diagnosed
- ejection fraction
- quality improvement
- chronic kidney disease
- palliative care
- type diabetes
- mental health
- prognostic factors
- peritoneal dialysis
- emergency department
- metabolic syndrome
- chronic pain
- cardiovascular risk factors
- coronary artery disease
- patient reported outcomes
- pain management
- drug induced
- electronic health record
- long term care